David E. Cohen

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Gregory S. Moss, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David E. Cohen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Timber Pharmaceuticals, Inc. Director Common Stock, par value $0.001 per share 6,100 $9,937 $1.63 15 Apr 2023 Direct
Evommune, Inc. Director Stock Option (Right to Buy) 37,960 05 Nov 2025 Direct
Evommune, Inc. Director Common Stock 23,665 07 Nov 2025 Direct
Timber Pharmaceuticals, Inc. Director Stock Option (right to buy) 4,100 15 Apr 2023 Direct
Evommune, Inc. Director Series Seed Preferred Stock 0 07 Nov 2025 Direct
Kadmon Holdings, Inc. Director Stock Option (right to buy) 0 $5.54 09 Nov 2021 Direct

Insider Reports Filed by David E. Cohen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000134738325000009-cohen-david-e-2025-11-07 Evommune, Inc. 07 Nov 2025 2 $0 4 Director 12 Nov 2025, 16:17
/report/000134738325000007-cohen-david-e-2025-11-05 Evommune, Inc. 05 Nov 2025 1 $0 4 Director 07 Nov 2025, 16:15
/report/000134738325000005-cohen-david-e-2025-11-05 Evommune, Inc. 05 Nov 2025 0 $0 3 Director 05 Nov 2025, 20:02
/report/000143774923010513-cohen-david-e-2023-04-15 Timber Pharmaceuticals, Inc. 15 Apr 2023 2 $0 4 Director 18 Apr 2023, 11:32
/report/000110465922047218-cohen-david-e-2022-04-15 Timber Pharmaceuticals, Inc. 15 Apr 2022 2 $0 4 Director 19 Apr 2022, 12:59
/report/000110465921136401-cohen-david-e-2021-11-09 Kadmon Holdings, Inc. 09 Nov 2021 4 -$2,194,844 4 Director 09 Nov 2021, 16:37
/report/000110465921089394-cohen-david-e-2021-07-01 Timber Pharmaceuticals, Inc. 01 Jul 2021 1 $0 4 Director 06 Jul 2021, 16:06
/report/000159396821001311-cohen-david-e-2021-05-12 Kadmon Holdings, Inc. 12 May 2021 1 $0 4 Director 13 May 2021, 16:10